ReGen Therapeutics Limited Competition

Who would have thought that cow's milk could help your brain? ReGen Therapeutics did. Its main product is Colostrinin, a polypeptide nutraceutical derived from ovine and bovine colostrums (the first milk produced after the birth of an offspring) that has been shown to have neurological benefits for sufferers of ailments such as Alzheimer's disease and multiple sclerosis. The supplement is marketed as CogniSure by licensee Metagenics in North America, Australia, and parts of Asia. It is sold by other partners in additional markets including the UK (MemoryAid), Poland, Turkey, Cyprus, and India. ReGen is working to expand sales of Colostrinin into new markets.